ATAI

NASDAQ · Pharmaceuticals

Ataibeckley Inc

Mid-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$7.25

+0.07 (+0.97%)

As of Aug 8, 10:09 PM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 9 43%

Hold 12 57%

Sell 0 0%

Price Target

Analyst Price Target +457.8% upside

Low Target $27.58

Average Target $40.44

High Target $50.46

Current Price $7.25

Current
$7.25

Target
$40.44

$27.58 $40.44 avg $50.46

Scenario Analysis

Bear Case

$27.58

280.4%

Low target

Base Case

$40.44

+457.8%

Avg target

Bull Case

$50.46

+596.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$7.22

0.4% from high

52-Week Low

$3.27

+122.1% from low

Target vs 52W High

$40.44

+460.1% vs high

Next Earnings Report

Aug 10, 2026

Today

EPS Est: $-0.10

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%